Stephen R. Brady - Jan 2, 2025 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
President and CEO, Director
Signature
/s/ Nicholas Maestas, Attorney-in-Fact
Stock symbol
TPST
Transactions as of
Jan 2, 2025
Transactions value $
$0
Form type
4
Date filed
1/6/2025, 05:00 PM
Previous filing
Jul 8, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Employee Stock Option (right to buy) Award $0 +550K $0.00 550K Jan 2, 2025 Common Stock 550K $0.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest in a series of 48 equal monthly installments measured from January 2, 2025, subject to the Reporting Person's continued service.